Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 5 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: E9B1Y4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.605 |
CLV_NRD_NRD_1 | 142 | 144 | PF00675 | 0.527 |
CLV_NRD_NRD_1 | 91 | 93 | PF00675 | 0.532 |
CLV_PCSK_KEX2_1 | 142 | 144 | PF00082 | 0.532 |
CLV_PCSK_KEX2_1 | 222 | 224 | PF00082 | 0.506 |
CLV_PCSK_KEX2_1 | 85 | 87 | PF00082 | 0.535 |
CLV_PCSK_KEX2_1 | 91 | 93 | PF00082 | 0.537 |
CLV_PCSK_PC1ET2_1 | 222 | 224 | PF00082 | 0.506 |
CLV_PCSK_PC1ET2_1 | 85 | 87 | PF00082 | 0.448 |
CLV_PCSK_SKI1_1 | 19 | 23 | PF00082 | 0.587 |
CLV_PCSK_SKI1_1 | 91 | 95 | PF00082 | 0.606 |
DEG_APCC_DBOX_1 | 18 | 26 | PF00400 | 0.377 |
DOC_MAPK_RevD_3 | 70 | 86 | PF00069 | 0.343 |
DOC_PP2B_PxIxI_1 | 111 | 117 | PF00149 | 0.705 |
DOC_PP4_FxxP_1 | 188 | 191 | PF00568 | 0.718 |
DOC_USP7_MATH_1 | 153 | 157 | PF00917 | 0.729 |
DOC_USP7_MATH_1 | 191 | 195 | PF00917 | 0.759 |
DOC_USP7_MATH_1 | 37 | 41 | PF00917 | 0.489 |
DOC_USP7_MATH_1 | 47 | 51 | PF00917 | 0.577 |
DOC_WW_Pin1_4 | 107 | 112 | PF00397 | 0.626 |
DOC_WW_Pin1_4 | 125 | 130 | PF00397 | 0.614 |
DOC_WW_Pin1_4 | 145 | 150 | PF00397 | 0.694 |
DOC_WW_Pin1_4 | 25 | 30 | PF00397 | 0.461 |
DOC_WW_Pin1_4 | 43 | 48 | PF00397 | 0.460 |
LIG_14-3-3_CanoR_1 | 13 | 22 | PF00244 | 0.446 |
LIG_14-3-3_CanoR_1 | 174 | 179 | PF00244 | 0.628 |
LIG_14-3-3_CanoR_1 | 86 | 94 | PF00244 | 0.756 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.356 |
LIG_BIR_III_2 | 179 | 183 | PF00653 | 0.697 |
LIG_BRCT_BRCA1_1 | 64 | 68 | PF00533 | 0.296 |
LIG_EH_1 | 185 | 189 | PF12763 | 0.709 |
LIG_FHA_1 | 133 | 139 | PF00498 | 0.666 |
LIG_FHA_1 | 47 | 53 | PF00498 | 0.470 |
LIG_FHA_1 | 69 | 75 | PF00498 | 0.260 |
LIG_FHA_2 | 128 | 134 | PF00498 | 0.702 |
LIG_FHA_2 | 253 | 259 | PF00498 | 0.645 |
LIG_Integrin_RGD_1 | 101 | 103 | PF01839 | 0.436 |
LIG_LIR_Nem_3 | 65 | 70 | PF02991 | 0.296 |
LIG_MLH1_MIPbox_1 | 64 | 68 | PF16413 | 0.296 |
LIG_Pex14_2 | 4 | 8 | PF04695 | 0.440 |
LIG_SH2_CRK | 232 | 236 | PF00017 | 0.735 |
LIG_SH2_NCK_1 | 124 | 128 | PF00017 | 0.754 |
LIG_SH2_STAT5 | 11 | 14 | PF00017 | 0.451 |
LIG_SH2_STAT5 | 79 | 82 | PF00017 | 0.700 |
LIG_SH3_3 | 181 | 187 | PF00018 | 0.707 |
LIG_SH3_3 | 233 | 239 | PF00018 | 0.644 |
LIG_SUMO_SIM_anti_2 | 71 | 77 | PF11976 | 0.236 |
LIG_SUMO_SIM_par_1 | 58 | 63 | PF11976 | 0.223 |
LIG_TRAF2_1 | 134 | 137 | PF00917 | 0.737 |
LIG_TRAF2_1 | 235 | 238 | PF00917 | 0.817 |
LIG_TRAF2_1 | 244 | 247 | PF00917 | 0.733 |
LIG_WRC_WIRS_1 | 253 | 258 | PF05994 | 0.647 |
MOD_CK1_1 | 107 | 113 | PF00069 | 0.669 |
MOD_CK1_1 | 125 | 131 | PF00069 | 0.709 |
MOD_CK1_1 | 156 | 162 | PF00069 | 0.677 |
MOD_CK1_1 | 189 | 195 | PF00069 | 0.748 |
MOD_CK1_1 | 31 | 37 | PF00069 | 0.455 |
MOD_CK1_1 | 46 | 52 | PF00069 | 0.455 |
MOD_CK1_1 | 58 | 64 | PF00069 | 0.236 |
MOD_CK1_1 | 84 | 90 | PF00069 | 0.560 |
MOD_CK2_1 | 127 | 133 | PF00069 | 0.743 |
MOD_CK2_1 | 190 | 196 | PF00069 | 0.756 |
MOD_CK2_1 | 241 | 247 | PF00069 | 0.694 |
MOD_Cter_Amidation | 89 | 92 | PF01082 | 0.396 |
MOD_GlcNHglycan | 106 | 109 | PF01048 | 0.483 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.505 |
MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.595 |
MOD_GlcNHglycan | 227 | 230 | PF01048 | 0.617 |
MOD_GlcNHglycan | 264 | 267 | PF01048 | 0.445 |
MOD_GlcNHglycan | 34 | 37 | PF01048 | 0.674 |
MOD_GlcNHglycan | 39 | 42 | PF01048 | 0.708 |
MOD_GlcNHglycan | 62 | 65 | PF01048 | 0.289 |
MOD_GSK3_1 | 103 | 110 | PF00069 | 0.683 |
MOD_GSK3_1 | 127 | 134 | PF00069 | 0.677 |
MOD_GSK3_1 | 186 | 193 | PF00069 | 0.705 |
MOD_GSK3_1 | 24 | 31 | PF00069 | 0.434 |
MOD_GSK3_1 | 37 | 44 | PF00069 | 0.450 |
MOD_GSK3_1 | 46 | 53 | PF00069 | 0.424 |
MOD_GSK3_1 | 58 | 65 | PF00069 | 0.239 |
MOD_GSK3_1 | 81 | 88 | PF00069 | 0.563 |
MOD_GSK3_1 | 9 | 16 | PF00069 | 0.456 |
MOD_N-GLC_1 | 103 | 108 | PF02516 | 0.433 |
MOD_N-GLC_1 | 31 | 36 | PF02516 | 0.680 |
MOD_N-GLC_1 | 37 | 42 | PF02516 | 0.686 |
MOD_NEK2_1 | 122 | 127 | PF00069 | 0.712 |
MOD_NEK2_1 | 230 | 235 | PF00069 | 0.767 |
MOD_NEK2_1 | 55 | 60 | PF00069 | 0.350 |
MOD_NEK2_1 | 62 | 67 | PF00069 | 0.305 |
MOD_NEK2_1 | 68 | 73 | PF00069 | 0.293 |
MOD_PIKK_1 | 127 | 133 | PF00454 | 0.681 |
MOD_PKA_1 | 13 | 19 | PF00069 | 0.359 |
MOD_PKA_1 | 85 | 91 | PF00069 | 0.659 |
MOD_PKA_2 | 12 | 18 | PF00069 | 0.435 |
MOD_PKA_2 | 50 | 56 | PF00069 | 0.416 |
MOD_PKA_2 | 85 | 91 | PF00069 | 0.745 |
MOD_Plk_1 | 47 | 53 | PF00069 | 0.385 |
MOD_Plk_2-3 | 247 | 253 | PF00069 | 0.640 |
MOD_Plk_4 | 55 | 61 | PF00069 | 0.393 |
MOD_ProDKin_1 | 107 | 113 | PF00069 | 0.624 |
MOD_ProDKin_1 | 125 | 131 | PF00069 | 0.614 |
MOD_ProDKin_1 | 145 | 151 | PF00069 | 0.695 |
MOD_ProDKin_1 | 25 | 31 | PF00069 | 0.461 |
MOD_ProDKin_1 | 43 | 49 | PF00069 | 0.459 |
TRG_DiLeu_BaEn_4 | 136 | 142 | PF01217 | 0.705 |
TRG_ENDOCYTIC_2 | 77 | 80 | PF00928 | 0.636 |
TRG_ER_diArg_1 | 141 | 143 | PF00400 | 0.714 |
TRG_ER_diArg_1 | 173 | 176 | PF00400 | 0.706 |
TRG_ER_diArg_1 | 91 | 93 | PF00400 | 0.672 |
TRG_Pf-PMV_PEXEL_1 | 142 | 146 | PF00026 | 0.505 |
TRG_Pf-PMV_PEXEL_1 | 176 | 181 | PF00026 | 0.446 |
TRG_Pf-PMV_PEXEL_1 | 92 | 97 | PF00026 | 0.520 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IFE3 | Leishmania donovani | 77% | 100% |
A4I6W0 | Leishmania infantum | 77% | 100% |
E9AIU6 | Leishmania braziliensis | 51% | 99% |
Q4Q676 | Leishmania major | 69% | 98% |